Analytik

Activities: Analysis

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
  3. LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
  4. Memel Biotech and Therabest collaborate to develop exosome-based cell therapies The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
  5. Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

Related Content

Manufacturing

Microfluidizer offers effective cell disruption

The School of Biological and Chemical Sciences at QMUL chooses the Analytik LM20 Microfluidizer
Manufacturing

Analytik exclusive distributors for OEM FT-NIR in UK and Ireland

Analytik appointed exclusive distributors for NeoSpectra, part of Si-Ware Systems, to provide the miniaturised OEM FT-NIR spectral sensors to the UK and Ireland
You need to be a subscriber to read this article.
Click here to find out more.
Analysis

Multispectral imaging as a QA/QC tool

Multispectral imaging can measure colour, texture, gloss, shape and size to provide useful information on a finished pharma product, on the raw materials or on the manufacturing process. The technology offers rapid screening for out-of-specification tablets and contaminated powders; is suitable for the objective measurement of tablet defects; determines how well the ingredients of formulations are blended; and can be used to identify counterfeits through analysis of both packaging and product
Subscribe now